Funding Agencies:
IP is supported by grants from the Swedish Rheumatism Association (R-995882), Lupus Research Alliance, King Gustaf V’s 80-year Foundation (FAI-2023-1055), Swedish Society of Medicine (SLS-974449), Nyckelfonden (OLL-1000881), Professor Nanna Svartz Foundation (2021-00436), Ulla and Roland Gustafsson Foundation (2024-43), Region Stockholm (FoUI-1004114), and Karolinska Institutet (2024-03145). Funding for the preparation of this supplement was supported by UCB and Biogen.